Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.
Keyword: innovation
The 250-year-old Semmelweis University and Egis Pharmaceuticals have signed a cooperation agreement
The Semmelweis University and Egis Pharmaceuticals PLC have agreed on an even closer and better structured cooperation than before. Their common goal is to further raise the standards of pharmaceutical R+D as well as pharmacist and doctor training by making use of the synergies in each other’s activities. As a result of the agreement, new health industrial innovations can be launched and the Semmelweis University can be extended with more practical educational and training elements that also meet the needs of the Hungarian pharmaceutical industry.
Channels
Egis' products are sold to 100 countries.
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
In the 2022/2023 business year, the company’s product portfolio consisted of 653 products
In the 2022/2023 business year, we spent EUR 48 million on research and development
Healthcare and sharing knowledge are in the heart of our CSR activities
Our highlighted past and future events you shouldn't miss
Your browser is out of date. Please, use an updated version!